About this trial
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis.
The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life.
From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros.
This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient, male or female, over the age of 18
Patient with a FINDRISC score ≥10 points
Beneficiary of a French health insurance system
Patient having been informed and having given their consent free, enlightened and written
Disqualifiers
Patient over 75 years old
Patient already diagnosed with type 2 diabetes
Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.
Patient participating in another research
Trial design
Parallel
Treatments tested in this trial
Study nurse intervention
BehavioralContact everay 4 months with a dedicated study nurse
Treatment groups
Trial outcomes
Primary outcomes
FINDRISC score
FINDRISC is a prediction tool to identify patients at risk of developing diabetes without biological analysis.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ramsay Générale de Santé
Lead sponsor
European Clinical Trial Experts Network
Collaborator